Expert guidance in PD and biomarker sample logistics, translational medicine support, and biorepository strategy for pharma and biotech programs.
Specialized consulting across the full biospecimen lifecycle — from protocol design to data delivery.
End-to-end coordination of pharmacodynamics and biomarker sample collection, processing, shipment, and delivery to central labs and third-party analytical vendors.
Design and scale biobank operations from the ground up, including inventory systems, LIMS implementation, and SOP development for high-throughput specimen handling.
Vendor identification, qualification, contract initiation, and budget management. Ongoing performance tracking and query resolution to keep studies on timeline.
Ensure biosample operations meet ICF, IRB, GCP, CLIA, and IATA standards. Audit preparation, deviation management, and CAPA implementation.
Draft and review lab manuals, collection guides, and requisition forms aligned with study protocols and clinical needs across single and multi-site trials.
Bridge scientific and clinical operations by embedding in study teams, establishing analytical workflows, and ensuring biomarker data delivery supports TM program goals.
8+ years managing biosample logistics across oncology clinical trials, federal research, and pharmaceutical programs.
I specialize in building and optimizing biosample operations for pharma, biotech, and federal research programs. My background spans hematological oncology trials, BSL-3/4 biorepository management, and multi-site clinical study support — giving me a rare combination of scientific depth and operational precision.
I've managed over 100,000 human samples, led LIMS implementations, and served as the translational medicine voice on clinical study teams. Whether you need to stand up a biobank, fix a broken logistics workflow, or prepare for an audit, I bring hands-on expertise and structured execution.
Reach out to discuss your biosample operations needs. I respond within 24 hours.
"I work with pharmaceutical companies, biotechs, CROs, and federal research institutions to optimize biosample operations at any stage of a clinical program — from protocol design through final data delivery."